2Van Haeften TW. Clinical significance of insulin antibodies in insulin-treated diabetic patients. Diabetes Care , 1989,12:641.
3Fineberg SE, Galloway JA, Fineberg NS, et al. Immunogenicity of recombinant DNA human insulin. Diabetologia,1983,25:465.
4Schernthaner G. Immunogenicity and allergic potential of animal and human insulins. Diabetes Care, 1993,16:155.
5Ottesen JL, Nilsson P, Jami J, et al. The potential immunogenity of human insulin and insulin analogues evaluated in a transgenic mouse model. Diabetologia, 1994,37 : 1178.
6Uchigata Y, Eguchi Y, Takayama-Hasumi S, et al. Insulin autoimmune syndrome (Hirata Disease) : clinical features and epidemiology in Japan. Diabetes Res Clin Pract, 1994,22:89.
7Radermecker RP, Renard E, Scheen AJ. Circulating insulin antibodies: influence of continuous subcutaneous or intraperitoneal insulin infusion, and impact on glucose control. Diabetes Metab Res Rev, 2009,25 : 491.
8Boehm B, Vaz J, Br? ndsted L. , et al. Long term efficacy and safety of biphasic insulin aspart in patients with type 2 diabetes. Eur J Intern Med, 2004,15 : 496.
9Lindholm A, Jensen LB, Home PD, et al. Immune responses to insulin aspart and biphasic insulin aspart in people with type I and type 2 diabetes. Diabetes Care,2002,25 : 876.
10Raskin P, Guthrie RA, Leiter L, et al. Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes. Diabetes Care,2000,23: 583.
2Vitally ML, Timsit J, Chanson P, et al. Insulin autoimmune syndrome: a rare cause of hypoglycaemia not to he overlooked. Diabetes Metab, 1999,25: 429.
3Cavaco B, Uchigata Y, Porto T, et al. Hypoglycaemia due to insulin autoimmune syndrome: report of two cases with characterisation of HLA alleles and insulin autoantibodies. Eur J Endocrinol,2001,145:311.
4Yamasaki H, Yamaguchi Y, Fujita N, et al. Anti-insulin receptor autoantibodies in a patient with type B insulin resistance and fasting hypoglycemia. Acta Diabetol,2000,37:189.
5Baird JS, Johnson JL, Elliott-Mills D, et al. Systemic lupus erythematosus with acanthosis nigricans, hyperpigmentation, and insulin receptor antibody. Lupus, 1997,6:275.
6Magsino CH Jr, Spencer J. Insulin receptor antibodies and insulin resistance. South Med J,1999,92:717.
9Abrahamian H,Endler G,Exner M,et al. Association of low-gradeinflammation with nephropathy in type 2 diabetic patients : role ofelevated C-RP levels and 2 different gene-polymorphisms ofproinflammatory cytokines. Exp Clin Endocrinol Diabetes,2007,115(1) :3841.
10Kelly KJ, Wu PF,Patterson CE,et al. LOX-1 and inflammation:anewmechanism for renal injury in obesity and diabetes. Am Physi-ol Renal Physiol,2008,294(5) :1136-1145.
